Cargando…
Imaging of COVID-19: An update of current evidences
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been reported as a global emergency. As respiratory dysfunction is a major clinical presentation of COVID-19, chest computed tomography (CT) plays a central role in the diagnosis and mana...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française de radiologie. Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148573/ https://www.ncbi.nlm.nih.gov/pubmed/34088635 http://dx.doi.org/10.1016/j.diii.2021.05.006 |
_version_ | 1783697870949449728 |
---|---|
author | Kato, Shingo Ishiwata, Yoshinobu Aoki, Ryo Iwasawa, Tae Hagiwara, Eri Ogura, Takashi Utsunomiya, Daisuke |
author_facet | Kato, Shingo Ishiwata, Yoshinobu Aoki, Ryo Iwasawa, Tae Hagiwara, Eri Ogura, Takashi Utsunomiya, Daisuke |
author_sort | Kato, Shingo |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been reported as a global emergency. As respiratory dysfunction is a major clinical presentation of COVID-19, chest computed tomography (CT) plays a central role in the diagnosis and management of patients with COVID-19. Recent advances in imaging approaches using artificial intelligence have been essential as a quantification and diagnostic tool to differentiate COVID-19 from other respiratory infectious diseases. Furthermore, cardiovascular involvement in patients with COVID-19 is not negligible and may result in rapid worsening of the disease and sudden death. Cardiac magnetic resonance imaging can accurately depict myocardial involvement in SARS-CoV-2 infection. This review summarizes the role of the radiology department in the management and the diagnosis of COVID-19, with a special emphasis on ultra-high-resolution CT findings, cardiovascular complications and the potential of artificial intelligence. |
format | Online Article Text |
id | pubmed-8148573 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Société française de radiologie. Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81485732021-05-26 Imaging of COVID-19: An update of current evidences Kato, Shingo Ishiwata, Yoshinobu Aoki, Ryo Iwasawa, Tae Hagiwara, Eri Ogura, Takashi Utsunomiya, Daisuke Diagn Interv Imaging Review Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been reported as a global emergency. As respiratory dysfunction is a major clinical presentation of COVID-19, chest computed tomography (CT) plays a central role in the diagnosis and management of patients with COVID-19. Recent advances in imaging approaches using artificial intelligence have been essential as a quantification and diagnostic tool to differentiate COVID-19 from other respiratory infectious diseases. Furthermore, cardiovascular involvement in patients with COVID-19 is not negligible and may result in rapid worsening of the disease and sudden death. Cardiac magnetic resonance imaging can accurately depict myocardial involvement in SARS-CoV-2 infection. This review summarizes the role of the radiology department in the management and the diagnosis of COVID-19, with a special emphasis on ultra-high-resolution CT findings, cardiovascular complications and the potential of artificial intelligence. Société française de radiologie. Published by Elsevier Masson SAS. 2021-09 2021-05-25 /pmc/articles/PMC8148573/ /pubmed/34088635 http://dx.doi.org/10.1016/j.diii.2021.05.006 Text en © 2021 Société française de radiologie. Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Kato, Shingo Ishiwata, Yoshinobu Aoki, Ryo Iwasawa, Tae Hagiwara, Eri Ogura, Takashi Utsunomiya, Daisuke Imaging of COVID-19: An update of current evidences |
title | Imaging of COVID-19: An update of current evidences |
title_full | Imaging of COVID-19: An update of current evidences |
title_fullStr | Imaging of COVID-19: An update of current evidences |
title_full_unstemmed | Imaging of COVID-19: An update of current evidences |
title_short | Imaging of COVID-19: An update of current evidences |
title_sort | imaging of covid-19: an update of current evidences |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148573/ https://www.ncbi.nlm.nih.gov/pubmed/34088635 http://dx.doi.org/10.1016/j.diii.2021.05.006 |
work_keys_str_mv | AT katoshingo imagingofcovid19anupdateofcurrentevidences AT ishiwatayoshinobu imagingofcovid19anupdateofcurrentevidences AT aokiryo imagingofcovid19anupdateofcurrentevidences AT iwasawatae imagingofcovid19anupdateofcurrentevidences AT hagiwaraeri imagingofcovid19anupdateofcurrentevidences AT oguratakashi imagingofcovid19anupdateofcurrentevidences AT utsunomiyadaisuke imagingofcovid19anupdateofcurrentevidences |